We are excited to share the latest work from our MESOMICS project in which we disentangle the molecular, clinical and morphological heterogeneity of malignant pleural mesothelioma (MPM) using deep integrative omics analyses: https://biorxiv.org/cgi/content/short/2021.09.27.461908v1. MPM is a rare aggressive cancer associated with asbestos exposure. In the past decade, knowledge on the molecular profile of MPM has
Check out our recent published paper on GigaScience: A molecular map of lung neuroendocrine neoplasms.
Full paper can be found here. We invite you also to read the Q&A with Matthieu Foll about Accessing and reviewing Controlled Access Data of Rare Cancers.
EBioMedicine journal’s website https://www.ebiomedicine.com/article/S2352-3964(19)30601-2/fulltext and ScienceDirect https://www.sciencedirect.com/science/article/pii/S2352396419306012.